Scarica l'app Stockscreener
406.21
1.32%
-5.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$411.49
Aprire:
$409.47
Volume 24 ore:
436.80K
Relative Volume:
0.56
Capitalizzazione di mercato:
$32.79B
Reddito:
$3.90B
Utile/perdita netta:
$887.87M
Rapporto P/E:
38.07
EPS:
10.67
Flusso di cassa netto:
$798.08M
1 W Prestazione:
+0.35%
1M Prestazione:
-3.55%
6M Prestazione:
-10.44%
1 anno Prestazione:
-14.75%
Intervallo 1D:
$405.32
$412.31
Intervallo di 1 settimana:
$398.75
$412.62
Portata 52W:
$356.14
$548.88
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
406.46 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
TMO
Thermo Fisher Scientific Inc
|
419.65 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
183.09 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
99.73 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
138.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Leerink Partners Adjusts Price Target on IDEXX Laboratories to $500 From $525, Maintains Outperform Rating - marketscreener.com
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? - Yahoo Finance
Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $548 From $559, Keeps Overweight Rating - marketscreener.com
Idexx Laboratories (IDXX): Morgan Stanley Adjusts Price Target, Maintains Overweight Rating | IDXX Stock News - GuruFocus
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Amidst Innovation Analysis | IDXX Stock News - GuruFocus
Stifel Adjusts IDEXX Laboratories' PT to $420 From $450, Keeps Hold Rating - MarketScreener
IDEXX Laboratories: I Love The Business, Not The Stock Price (NASDAQ:IDXX) - Seeking Alpha
IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains? - Yahoo Finance
IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility - Yahoo Finance
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
Should You Sell IDEXX Laboratories (IDXX)? - MSN
How Is The Market Feeling About IDEXX Laboratories? - Benzinga
IDEXX Laboratories to Release 2025 First Quarter Financial Results - 01net
Pet Healthcare Leader IDEXX Sets Key Q1 2025 Earnings DateWhat Analysts Are Watching - Stock Titan
US judge dismisses most of consumer lawsuit over veterinary service prices - Reuters
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease - simplywall.st
Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000 - Yahoo Finance
Form DEF 14A IDEXX LABORATORIES INC For: Dec 31 - StreetInsider.com
Howe & Rusling Inc. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey
8 Best Pet Stocks to Buy According to Billionaires - Insider Monkey
Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey
IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - Yahoo Finance
12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey
Idexx's Economic Moat Remains Solid, but Softer Consumer Confidence Could Weigh on Near Term - Morningstar
Should You Retain IDEXX Stock in Your Portfolio for Now? - TradingView
IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To ‘Buy’ (NASDAQ:IDXX) - Seeking Alpha
Is IDEXX Laboratories Stock Underperforming the Nasdaq? - Nasdaq
The total return for IDEXX Laboratories (NASDAQ:IDXX) investors has risen faster than earnings growth over the last five years - Simply Wall St
Is IDEXX Laboratories Stock Underperforming The Nasdaq? - Barchart
Jones Financial Companies Lllp Sells 194 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Insider Monkey
Two Texas solar plants serve four buyers through energy attribute certificates - pv magazine USA
X-ELIO closes six US PPAs with Cisco, Biogen, IDEXX, and Waters Corporation - Morningstar
IDEXX Laboratories: A Top Dog In The Pet Care Market (NASDAQ:IDXX) - Seeking Alpha
Steward Partners Investment Advisory LLC Purchases 218 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Oppenheimer & Co. Inc. - Defense World
IDEXX Laboratories, Inc. to Host Earnings Call - ACCESS Newswire
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Assetmark Inc. - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Cut to Hold at StockNews.com - Defense World
Idexx (IDXX) Down 5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
FFT Wealth Management LLC Makes New $227,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Illinois Municipal Retirement Fund Sells 1,017 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Sigma Planning Corp - MarketBeat
738 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Bought by JFG Wealth Management LLC - MarketBeat
Amalgamated Bank Sells 684 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Upgraded by StockNews.com to "Buy" Rating - MarketBeat
Sterling Investment Advisors Ltd. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):